JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB109365

Anti-TWEAKR/FN14 antibody [EPR3179]

5

(4 Reviews)

|

(36 Publications)

Anti-TWEAKR/FN14 antibody [EPR3179] (ab109365) is a rabbit monoclonal antibody detecting TWEAKR/FN14 in Western Blot, IP. Suitable for Human, Mouse, Rat.

- Biophysical QC for unrivalled batch-batch consistency
- Over 20 publications

View Alternative Names

CD266, FN14, TNFRSF12A, Tumor necrosis factor receptor superfamily member 12A, Fibroblast growth factor-inducible immediate-early response protein 14, Tweak-receptor, FGF-inducible 14, TweakR

5 Images
Immunoprecipitation - Anti-TWEAKR/FN14 antibody [EPR3179] (AB109365)
  • IP

Lab

Immunoprecipitation - Anti-TWEAKR/FN14 antibody [EPR3179] (AB109365)

ab109365 at 1/40 immunoprecipitating TWEAKR/FN14 in HUVEC (human cervix adenocarcinoma) whole cell lysate observed at 14 – 17 KDa (lanes 1 and 2).

Lane 1 (input) : HUVEC whole cell lysate 10ug

Lane 2 (+) : ab109365 + HUVEC whole cell lysate.

Lane 3 (-) : Rabbit monoclonal IgG (ab172730) instead of ab109365 in HUVEC whole cell lysate

VeriBlot for IP Detection Reagent (HRP) (ab131366), was used for detection at 1/10,000 dilution.

Blocking/Diluting buffer and concentration : 5% NFDM/TBST.

All lanes:

Immunoprecipitation - Anti-TWEAKR/FN14 antibody [EPR3179] (ab109365)

Predicted band size: 14 kDa

false

Western blot - Anti-TWEAKR/FN14 antibody [EPR3179] (AB109365)
  • WB

Unknown

Western blot - Anti-TWEAKR/FN14 antibody [EPR3179] (AB109365)

All lanes:

Western blot - Anti-TWEAKR/FN14 antibody [EPR3179] (ab109365) at 1/1000 dilution

Lane 1:

HT-29 cell lysate at 10 µg

Lane 2:

HUVEC cell lysate at 10 µg

Lane 3:

HT-1080 cell lysate at 10 µg

Predicted band size: 14 kDa

false

Western blot - Anti-TWEAKR/FN14 antibody [EPR3179] (AB109365)
  • WB

Unknown

Western blot - Anti-TWEAKR/FN14 antibody [EPR3179] (AB109365)

Lanes 1 - 2:

Western blot - Anti-TWEAKR/FN14 antibody [EPR3179] (ab109365) at 1/1000 dilution

Lanes 1 - 2:

Western blot - Anti-TWEAKR/FN14 antibody [EPR3179] - Low endotoxin, Azide free (<a href='/en-us/products/primary-antibodies/tweakr-fn14-antibody-epr3179-low-endotoxin-azide-free-ab228481'>ab228481</a>) at 1/1000 dilution

Lane 1:

HUVEC (human umbilical vein/vascular endothelium) whole cell lysate at 20 µg

Lane 2:

HT-1080 (human fibrosarcoma) whole cell lysate at 20 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution

Predicted band size: 14 kDa,70 kDa

Observed band size: 110 kDa,14-17 kDa

false

Western blot - Anti-TWEAKR/FN14 antibody [EPR3179] (AB109365)
  • WB

Unknown

Western blot - Anti-TWEAKR/FN14 antibody [EPR3179] (AB109365)

All lanes:

Western blot - Anti-TWEAKR/FN14 antibody [EPR3179] (ab109365) at 1/1000 dilution

Lane 1:

NIH/3T3 (mouse embryo) whole cell lysate at 20 µg

Lane 2:

L6 (rat skeletal muscle) whole cell lysate at 20 µg

Lane 3:

C2C12 (mouse muscle) whole cell lysate at 20 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution

Predicted band size: 14 kDa

Observed band size: 14-17 kDa

false

Western blot - Anti-TWEAKR/FN14 antibody [EPR3179] (AB109365)
  • WB

CiteAb

Western blot - Anti-TWEAKR/FN14 antibody [EPR3179] (AB109365)

TWEAKR/FN14 western blot using anti-TWEAKR/FN14 antibody [EPR3179] ab109365. Publication image and figure legend from Zou, Y., Lee, J., et al., 2014, PLoS One, PubMed 25222179.

ab109365 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab109365 please see the product overview.

Protein expression of CD133, Fn14, TFF3, HNF4α, p-Akt1 (T308), Akt1, p-p70S6K (T389), p70S6K, p-4E-BP1 (T37/46), and 4E-BP1 in regenerating livers of Nrf2+/+ and Nrf2−/− mice.Livers were collected from normal mice and the mice subjected to partial hepatectomy (PH) at the indicated time points following surgery. Liver lysates prepared from three mice per time point per genotype were pooled with equal amount of protein from each preparation. Western blot was performed with antibodies against the proteins indicated. Glyceraldehyde 3-phosphate dehydrogenase (GADPH) was used as a loading control. NL, normal liver.

false

  • Carrier free

    Anti-TWEAKR/FN14 antibody [EPR3179] - BSA and Azide free

  • Carrier free

    Anti-TWEAKR/FN14 antibody [EPR3179] - Low endotoxin, Azide free

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EPR3179

Isotype

IgG

Carrier free

No

Reacts with

Mouse, Rat, Human

Applications

WB, IP

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "", "IHCP-species-notes": "<p></p>", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "<p></p>", "IP-species-checked": "testedAndGuaranteed", "IP-species-dilution-info": "1/40", "IP-species-notes": "<p><strong>For unpurified use at 1/10.</strong></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000 - 1/10000", "WB-species-notes": "<p></p>" }, "Mouse": { "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "1/50 - 1/500", "IHCP-species-notes": "<p></p> Perform heat-mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "<p></p>", "IP-species-checked": "guaranteed", "IP-species-dilution-info": "", "IP-species-notes": "", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000 - 1/10000", "WB-species-notes": "<p></p>" }, "Rat": { "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "1/50 - 1/500", "IHCP-species-notes": "<p></p> Perform heat-mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "<p></p>", "IP-species-checked": "guaranteed", "IP-species-dilution-info": "", "IP-species-notes": "", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000 - 1/10000", "WB-species-notes": "<p></p>" } } }

Product details

What is this antibody validated in?
Anti-TWEAKR/FN14 antibody [EPR3179] (ab109365) is a rabbit recombinant monoclonal antibody and is validated for use in Western Blot (WB), Immunoprecipitation (IP) in Human, Mouse, Rat samples.

What is the molecular weight of TWEAKR/FN14?
Anti-TWEAKR/FN14 [EPR3179] (ab109365) specifically detects a band for TWEAKR/FN14 (UniProt: Q9NP84) at a molecular weight of 14kDa.

Trusted by the scientific community
Anti-TWEAKR/FN14 [EPR3179] (ab109365) was first used in a scientific publication in 2011 and has been cited over 20 times in peer-reviewed journals.

Trial sizes available!
Test your antibody or perform pre-screening before committing to a larger quantity. Sold in 10µl. Discover our selection of trial-size antibodies.

Other related products
We have a range of other formats of antibody clone [EPR3179] also available for your convenience: ab109365, Carrier free - ab228481, Carrier free - ab271881

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle|Stable for 12 months at -20°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

The TWEAKR/FN14 known also as FN14 protein is a receptor primarily involved in cellular signaling. It is found on the cell surface and has a molecular weight of approximately 14 kDa. This receptor expresses in various tissues but its expression is especially high in the liver kidney and muscle tissues. Through its engagement with its ligand TWEAK (Tumor Necrosis Factor-Like Weak Inducer of Apoptosis) TWEAKR/FN14 participates in signal transduction processes that regulate cell survival and proliferation.
Biological function summary

TWEAKR/FN14 influences multiple cellular activities including inflammation proliferation and apoptosis. It does not solely function in isolation often interacting with other proteins in complex networks. In fact FN14 often couples its activity with downstream signaling proteins that impact pathways involved in tissue remodeling and repair. The receptor's ability to mediate these processes makes it a significant regulator of tissue response to damage.

Pathways

Signaling through TWEAKR/FN14 primarily involves the NF-κB and MAPK pathways. These signaling pathways are critical for mediating cellular responses to external stimuli such as stress or injury. The NF-κB pathway in particular plays a role in immune and inflammatory responses where FN14 through its interaction modulates these responses. Additionally proteins such as TRAF (TNF Receptor Associated Factor) are related to FN14 through these pathways contributing to its signaling functions.

Dysregulation of TWEAKR/FN14 is linked to pathological conditions such as cancer and fibrosis. Overexpression of FN14 has been observed in several malignancies and its interaction with TWEAK has been implicated in tumorigenic processes. Meanwhile in fibrosis FN14 is associated with excessive tissue repair and scarring connected to the accumulation of extracellular matrix proteins. Altered expression levels and activity of FN14 with its partner proteins can contribute to the progression of these diseases highlighting its potential as a therapeutic target.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Receptor for TNFSF12/TWEAK. Weak inducer of apoptosis in some cell types. Promotes angiogenesis and the proliferation of endothelial cells. May modulate cellular adhesion to matrix proteins.
See full target information TNFRSF12A

Publications (36)

Recent publications for all applications. Explore the full list and refine your search

Nanoscale advances 7:2634-2647 PubMed40109505

2025

Fn14-targeting, NIR-II responsive nanomaterials for enhanced radiotherapy against glioblastomas.

Applications

Unspecified application

Species

Unspecified reactive species

Wei Fu,Qing Liang,Yuxi Ma,Shiqiong Lei,Ruiqi Li,Xin Zheng,Lian Chen,Jiayuan Chen,Xing Cai,Xiaofang Dai,Hongwei Duan,Wenshan He,Jinghua Ren

Journal of cachexia, sarcopenia and muscle 16:e13722 PubMed39901379

2025

Melatonin Ameliorates Age-Related Sarcopenia via the Gut-Muscle Axis Mediated by Serum Lipopolysaccharide and Metabolites.

Applications

Unspecified application

Species

Unspecified reactive species

Ling-Shan Zhou,Yuan Yang,Li Mou,Xin Xia,Min Liu,Ling-Jie Xu,Rong Liu,Jun-Ping Liu,Hai-Yan Zhang,Xiao-Jun Ao,Chang-Jiang Liu,Qian Xiao,Shi-Xiong Liu

Heliyon 10:e37935 PubMed39391467

2024

Anti-inflammatory Capacity of a Medicinal herb extract, , on and models-induced atopic dermatitis.

Applications

Unspecified application

Species

Unspecified reactive species

Hye-Min Kim,Yun-Mi Kang,Bo-Ram Jin,Minho Lee,Hyo-Jin An

Journal of cosmetic dermatology 23:4230-4238 PubMed39166480

2024

TWEAK increases angiogenesis to promote diabetic skin wound healing by regulating Fn14/EGFR signaling.

Applications

Unspecified application

Species

Unspecified reactive species

Ying-Jie Zhu,Hu-Lin Chen,Jing-Kai Huang,Xin-Jie Cai,Bang-le Zhan

Cancer research and treatment 57:212-228 PubMed39118523

2024

The Oncogenic Role of TNFRSF12A in Colorectal Cancer and Pan-Cancer Bioinformatics Analysis.

Applications

Unspecified application

Species

Unspecified reactive species

Chuyue Wang,Yingying Zhao,You Chen,Ying Shi,Zhiying Yang,Weili Wu,Rui Ma,Bo Wang,Yifeng Sun,Ping Yuan

iScience 27:109317 PubMed38500821

2024

Machine learning unveils immune-related signature in multicenter glioma studies.

Applications

Unspecified application

Species

Unspecified reactive species

Sha Yang,Xiang Wang,Renzheng Huan,Mei Deng,Zhuo Kong,Yunbiao Xiong,Tao Luo,Zheng Jin,Jian Liu,Liangzhao Chu,Guoqiang Han,Jiqin Zhang,Ying Tan

Science signaling 17:eade0580 PubMed38470957

2024

Cancer-associated fibroblasts produce matrix-bound vesicles that influence endothelial cell function.

Applications

Unspecified application

Species

Unspecified reactive species

Alice Santi,Emily J Kay,Lisa J Neilson,Lynn McGarry,Sergio Lilla,Margaret Mullin,Nikki R Paul,Frédéric Fercoq,Grigorios Koulouras,Giovanny Rodriguez Blanco,Dimitris Athineos,Susan Mason,Mark Hughes,Gemma Thomson,Yann Kieffer,Colin Nixon,Karen Blyth,Fatima Mechta-Grigoriou,Leo M Carlin,Sara Zanivan

Frontiers in immunology 14:1194610 PubMed37545514

2023

Antibody-based soluble and membrane-bound TWEAK mimicking agonists with FcγR-independent activity.

Applications

Unspecified application

Species

Unspecified reactive species

Olena Zaitseva,Annett Hoffmann,Margaretha Löst,Mohamed A Anany,Tengyu Zhang,Kirstin Kucka,Armin Wiegering,Christoph Otto,Harald Wajant

Molecular pharmaceutics 20:314-330 PubMed36374573

2022

Fn14-Directed DART Nanoparticles Selectively Target Neoplastic Cells in Preclinical Models of Triple-Negative Breast Cancer Brain Metastasis.

Applications

Unspecified application

Species

Unspecified reactive species

Christine P Carney,Anshika Kapur,Pavlos Anastasiadis,Rodney M Ritzel,Chixiang Chen,Graeme F Woodworth,Jeffrey A Winkles,Anthony J Kim

Disease models & mechanisms 15: PubMed36004645

2022

Exocyst inactivation in urothelial cells disrupts autophagy and activates non-canonical NF-κB signaling.

Applications

Unspecified application

Species

Unspecified reactive species

Michael A Ortega,Ross K Villiger,Malia Harrison-Chau,Suzanna Lieu,Kadee-Kalia Tamashiro,Amanda J Lee,Brent A Fujimoto,Geetika Y Patwardhan,Joshua Kepler,Ben Fogelgren
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com